Cobra and Symbiosis announce the completion of their collaboration on viral vector development and manufacturing, supported by £1.9m Innovate UK grant.
The dozens of ‘devastating, unprecedented and dangerous’ forest fires raging across Sweden are far from manufacturing and industrial centres, says Swedish Association of the Pharmaceutical Industry.
Cobra Biomanufacturing of the UK saw its losses halve in the first
half of the current fiscal year, in the face of continuing declines
in the market for contract manufacturing of plasmid DNA.
Cobra Biomanufacturing has granted AstraZeneca the right to use its
proprietary DNA manufacturing process to make nucleic acids for use
in its drug discovery operations.
Shares in Cobra Biomanufacturing of the UK fell 30 per cent
yesterday after the contract manufacturer of proteins, DNA and
viruses gave a warning on profits.
UK firm Cobra Biomanufacturing has ended its first year as a
publicly-listed company with a healthy 137 per cent increase in
revenues to £6 million (€8.6m), helped by an expansion of its
business in the US.
